The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
A general cardiovascular risk profile: The Framingham study
Abstract
Persons at high risk of cardiovascular disease can be effectively identified from a measurement of their serum cholesterol and blood pressure, a smoking history, an electrocardiogram and a determination of glucose intolerance. One general function for identifying persons at high risk of cardiovascular disease is also effective in identifying persons at risk for each of the specific diseases, coronary heart disease, atherothrombotic brain infarction, hypertensive heart disease and intermittent claudication, even though the variables used have a different impact on each particular disease. The 10 percent of persons identified with use of this function as at highest risk accounted for about one fifth of the 8 year incidence of coronary heart disease and about one third of the 8 year incidence of atherothrombotic brain infarction, hypertensive heart disease and intermittent claudication. Hence the function provides an economic and efficient method of identifying persons at high cardiovascular risk who need preventive treatment and persons at low risk who need not be alarmed about one moderately elevated risk characteristic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The 10-year risk estimates in the 1998 Framingham score classified people as low, intermediate, or high risk for future coronary heart disease.
“The 10-year risk estimates used in the 1998 score provided a convenient way to classify individuals as low, intermediate, or high risk for future coronary heart disease.”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [50]
The 1998 Wilson Framingham Risk Score for coronary heart disease became the basis of the risk calculator adopted by the Adult Treatment Panel of the National Cholesterol Education Program in the United States.
“The best known risk profile is the Framingham Risk Score for coronary heart disease, published in 1998 by Wilson and colleagues.50 This function became the basis of the risk calculator adopted by the Adult Treatment Panel of the National Cholesterol Education Program in the United States.51”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [50]
The 1998 Framingham risk model used risk factor categories instead of continuous values, allowing clinicians to use lookup tables for risk estimates.
“Compared with previously published functions, the 1998 model substituted risk factor categories in the place of continuous values, which enabled clinicians to use lookup tables to obtain risk estimates.”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [50]
The 1998 Framingham Risk Score, adopted by the National Cholesterol Education Program, contained both total and HDL cholesterol.
“Notably, the 1998 version of the Framingham Risk Score, adopted by the National Cholesterol Education Program, contained both total and HDL cholesterol.50”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [50]
Citations
Cites
Estimation of the Probability of an Event as a Function of Several Independent Variables
Walker, S. H., & Duncan, D. B. (1967) · Biometrika · doi:10.1093/biomet/54.1-2.167 · Cited by 1,683
Predisposition to Atherosclerosis in the Head, Heart, and Legs
Gordon, T. (1972) · JAMA · doi:10.1001/jama.1972.03200200011003 · Cited by 341
Self-citationThe role of impaired cardiac function in atherothrombotic brain infarction: the Framingham study.
Wolf, P. A., Kannel, W. B., Pm, M., & Gordon, T. (1973) · American Journal of Public Health · doi:10.2105/ajph.63.1.52 · Cited by 25
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 1970, Circulation, 42, A-55
Cited by
Sorted by citations
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176857 · Cited by 8,487
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Self-citationPencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,920
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.007 · Cited by 2,245
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E. R., Cahalane, S. F., Fowler, B., & Graham, I. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,160
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 2,110
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
An updated coronary risk profile. A statement for health professionals.
Anderson, K. M., Wilson, P. W., Odell, P. M., & Kannel, W. B. (1991) · Circulation · doi:10.1161/01.cir.83.1.356 · Cited by 1,834
Self-citationPresentation of multivariate data for clinical use: The Framingham Study risk score functions
SULLIVAN, L. M., Massaro, J. M., & D’Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1742 · Cited by 1,756
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.021 · Cited by 1,702
The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective
Mahmood, S. S., Levy, D., Vasan, R. S., & Wang, T. J. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61752-3 · Cited by 1,622
Prognosis and prognostic research: what, why, and how?
Moons, K. G. M., Royston, P., Vergouwe, Y., Grobbee, D. E., & Altman, D. G. (2009) · BMJ · doi:10.1136/bmj.b375 · Cited by 1,337
Greenland, P. (2007) · Statistics in Medicine · doi:10.1002/sim.2976 · Cited by 1,300
Perioperative Cardiac Morbidity
Mangano, D. T. (1990) · Anesthesiology · doi:10.1097/00000542-199001000-00025 · Cited by 1,178
ACC/AHA guidelines for the management of patients with valvular heart disease
Bonow, R. O., Carabello, B. A., de Leon, A., Edmunds, L. H., Fedderly, B. J., Freed, M. D., Gaasch, W. H., Cr, M., Nishimura, R., O’Gara, P. T., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00454-9 · Cited by 1,132
Bonow, R. O., Carabello, B. A., Chatterjee, K., de Leon, A. C., Faxon, D. P., Freed, M. D., Gaasch, W. H., Lytle, B. W., Nishimura, R. A., O’Gara, P. T., et al. (2008) · Circulation · doi:10.1161/circulationaha.108.190748 · Cited by 1,128
Mitchell, A. J., Vancampfort, D., Sweers, K., van Winkel, R., Yu, W., & Binder, M. D. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr148 · Cited by 1,120
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,119
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 997
Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
Ference, B. A., Robinson, J. G., Brook, R. D., Catapano, A. L., Chapman, M. J., Neff, D. R., Voros, S., Giugliano, R. P., Davey Smith, G., Fazio, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604304 · Cited by 743
Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population
Yang, X., Li, J., Hu, D., Chen, J., Li, Y., Huang, J., Liu, X., Liu, F., Cao, J., Shen, C., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022367 · Cited by 685
Epidemiological studies of CHD and the evolution of preventive cardiology
Wong, N. D. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.26 · Cited by 671
Risk factors for coronary artery disease in patients with systemic lupus erythematosus
Petri, M., Perez‐Gutthann, S., Spence, D., & Hochberg, M. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90578-y · Cited by 623
Longenecker, J. C., Coresh, J., Powe, N. R., Levey, A. S., Fink, N. E., Martin, A., & Klag, M. J. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000019641.41496.1e · Cited by 593
Primary and subsequent coronary risk appraisal: New results from the Framingham study
D’Agostino, R. B., Russell, M. W., Huse, D. M., Ellison, R. C., Silbershatz, H., Wilson, P. W. F., & Hartz, S. C. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90236-9 · Cited by 588
The Epidemiology of Varicose Veins: The Framingham Study
Brand, F. N., Dannenberg, A. L., Abbott, R. D., & Kannel, W. B. (1988) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)31203-0 · Cited by 568
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Preeclampsia and Cardiovascular Disease Death
Mongraw‐Chaffin, M., Cirillo, P. M., & Cohn, B. A. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.150078 · Cited by 436
Douglas, J. G. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.5.525 · Cited by 431
Santos, C. Y., Snyder, P. J., Wu, W., Zhang, M., Echeverria, A., & Alber, J. (2017) · Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · doi:10.1016/j.dadm.2017.01.005 · Cited by 431
Atherosclerotic Vascular Disease Conference
Faxon, D. P., Fuster, V., Libby, P., Beckman, J. A., Hiatt, W. R., Thompson, R. W., Topper, J. N., Annex, B. H., Rundback, J. H., Fabunmi, R. P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000128520.37674.ef · Cited by 421
O’Leary, D. H., & Polak, J. F. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02957-0 · Cited by 398
The Primary Prevention of Coronary Heart Disease in Women
Rich-Edwards, J. W., Manson, J. E., Hennekens, C. H., & Buring, J. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322607 · Cited by 383
Glynn, R. J., & ROSNER, B. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi309 · Cited by 380
Second Manifestations of ARTerial disease (SMART) study: Rationale and design
Simons, P. C. G., Algra, A., van der Laak, M. F., Grobbee, D. E., & van der Graaf, Y. (1999) · European Journal of Epidemiology · doi:10.1023/a:1007621514757 · Cited by 366
Predicting the Risk for Dialysis or Death in IgA Nephropathy
Berthoux, F. C., Mohey, H., Laurent, B., Mariat, C., Afiani, A., & Thibaudin, L. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040355 · Cited by 361
Estimating the likelihood of significant coronary artery disease
Pryor, D. B., Harrell, F. E., Lee, K. L., Califf, R. M., & Rosati, R. A. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90406-0 · Cited by 354
Pitsavos, C. S., Panagiotakos, D. B., Chrysohoou, C. A., & Stefanadis, C. (2003) · BMC Public Health · doi:10.1186/1471-2458-3-32 · Cited by 353
Evaluation of cardiovascular risk in the elderly: the Framingham study.
Kannel, W. B., & Gordan, T. (1978) · PubMed Central · Cited by 347
Self-citationStatistical methods for assessment of added usefulness of new biomarkers
Pencina, M. J., D’Agostino, R. B., & Vasan, R. S. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.340 · Cited by 335
Wofford, J. L., Kahl, F. R., Howard, G., McKinney, W. M., Toole, J. F., & Crouse, J. R. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.6.1786 · Cited by 335
The red wine hypothesis: from concepts to protective signalling molecules
Opie, L. H., & Lecour, S. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm149 · Cited by 337
Cardiovascular Disease Risk Assessment: Insights from Framingham
D’Agostino, R. B., Pencina, M. J., Massaro, J. M., & Coady, S. (2013) · Global Heart · doi:10.1016/j.gheart.2013.01.001 · Cited by 350
Wilson, P. W. F., Garrison, R. J., Castelli, W. P., Feinleib, M., McNamara, P. M., & Kannel, W. B. (1980) · The American Journal of Cardiology · doi:10.1016/0002-9149(80)90516-0 · Cited by 316
Self-citationAvolio, A. P., Butlin, M., & Walsh, A. (2009) · Physiological Measurement · doi:10.1088/0967-3334/31/1/r01 · Cited by 309
Harvard Report on Cancer Prevention Volume 4: Harvard Cancer Risk Index
Colditz, G. A., Atwood, K., Emmons, K. M., Monson, R. R., Willett, W. C., Trichopoulos, D., & Hunter, D. J. (2000) · Cancer Causes & Control · doi:10.1023/a:1008984432272 · Cited by 313
Wong, N. D., Budoff, M. J., Ferdinand, K. C., Graham, I. M., Michos, E. D., Reddy, T. K., Shapiro, M. D., & Toth, P. P. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100335 · Cited by 327
In-depth mining of clinical data: the construction of clinical prediction model with R
Zhou, Z., Wang, W., Li, Y., Jin, K., Wang, X., Wang, Z., Chen, Y.-S., Wang, S.-J., Hu, J., Zhang, H., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.08.63 · Cited by 300
Occupational Stress and Variation in Cigarette, Coffee, and Alcohol Consumption
Conway, T. L., Vickers, R. R., Ward, H., & Rahe, R. H. (1981) · Journal of Health and Social Behavior · doi:10.2307/2136291 · Cited by 300
Association of mitochondrial DNA copy number with cardiovascular disease
Ashar, F. N., Zhang, Y., Longchamps, R. J., Lane, J., Moes, A., Grove, M. L., Mychaleckyj, J. C., Taylor, K. D., Coresh, J., Rotter, J. I., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3683 · Cited by 295
Coresh, J., Kwiterovich, P., Smith, H., & Bachorik, P. S. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35731-x · Cited by 290
Diabetes as an atherogenic factor
Ruderman, N. B., & Haudenschild, C. C. (1984) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(84)90011-2 · Cited by 281
Diamond, G. A., Staniloff, H. M., Forrester, J. S., Pollock, B. H., & Swan, H. J. C. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80072-2 · Cited by 274
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279
Dietary fiber and coronary heart disease
Anderson, J. W., Deakins, D. A., Floore, T. L., Smith, B. M., & Whitis, S. E. (1990) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408399009527518 · Cited by 267
Cancer Risk Prediction Models: A Workshop on Development, Evaluation, and Application
Freedman, A. N., Seminara, D., Gail, M. H., Hartge, P. A., Colditz, G. A., Ballard-Barbash, R. R., & Pfeiffer, R. M. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji128 · Cited by 267
CHAUSSY, C. G., & Fuchs, G. J. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)41010-x · Cited by 265
KONES, R. J. (2011) · Drug Design Development and Therapy · doi:10.2147/dddt.s14934 · Cited by 265
Panagiotakos, D. B., Pitsavos, C. S., Chrysohoou, C. A., Skoumas, J., Tousoulis, D., Toutouza, M., TOUTOUZAS, P. K., & Stefanadis, C. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00442-3 · Cited by 258
Meta-analysis: metformin treatment in persons at risk for diabetes mellitus
Salpeter, S. R., Buckley, N. S., Kahn, J. A., & Salpeter, E. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.09.016 · Cited by 248
Exercise and the metabolic syndrome
Koivisto, V. A., Eriksson, J. G., & TAIMELA, S. P. (1997) · Diabetologia · doi:10.1007/s001250050653 · Cited by 249
Risk factors for pulmonary embolism
Goldhaber, S. Z., Savage, D. D., Garrison, R. J., Castelli, W. P., Kannel, W. B., McNamara, P. M., Gherardi, G. J., & Feinleib, M. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90805-7 · Cited by 247
Self-citationScreening for cardiovascular risk in asymptomatic patients
Berger, J. S., Jordan, C. O., Lloyd-Jones, D., & Blumenthal, R. S. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.066 · Cited by 238
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients
Wakkee, M., Thio, H. B., Prens, E. P., Sijbrands, E. J. G., & Neumann, H. A. M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.011 · Cited by 239
Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation.
Persson, J., Formgren, J., Israelsson, B., & Berglund, G. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.2.261 · Cited by 238
Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective.
Zoccali, C. (2006) · Kidney International · doi:10.1038/sj.ki.5000417 · Cited by 251
Cigarette Smoking and Flap and Full-Thickness Graft Necrosis
Goldminz, D. (1991) · Archives of Dermatology · doi:10.1001/archderm.1991.01680060086009 · Cited by 232
Bayesian Model Averaging in Proportional Hazard Models: Assessing the Risk of a Stroke
Volinsky, C. T., Madigan, D., Raftery, A. E., & Kronmal, R. A. (1997) · Journal of the Royal Statistical Society Series C: Applied Statistics · doi:10.1111/1467-9876.00082 · Cited by 226
Evidence for high risk of cerebral hemorrhage in chronic dialysis patients
Iseki, K., Kinjo, K., Kimura, Y., Osawa, A., & Fukiyama, K. (1993) · Kidney International · doi:10.1038/ki.1993.352 · Cited by 222
Predicting risk of dementia in older adults
Barnes, D. E., Covinsky, K. E., Whitmer, R. A., Kuller, L. H., López, O. L., & Yaffe, K. S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a81636 · Cited by 221
Gordon, T., & Kannel, W. B. (1982) · American Heart Journal · doi:10.1016/0002-8703(82)90567-1 · Cited by 216
Self-citationGijsberts, C. M., Groenewegen, K. A., Hoefer, I. E., Eijkemans, M. J. C., Asselbergs, F. W., Anderson, T. J., Britton, A. R., Dekker, J. M., Engström, G., Evans, G. W., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132321 · Cited by 197
Golden, S. H., Folsom, A. R., Coresh, J., Sharrett, A. R., Szklo, M., & Brancati, F. L. (2002) · Diabetes · doi:10.2337/diabetes.51.10.3069 · Cited by 199
The role of hypertension in hemodialysis-associated atherosclerosis
Vincenti, F. G., AMEND, W. J. C., Abele, J. S., Feduska, N. J., & Salvatierra, O. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90104-7 · Cited by 196
Mortality Risk Score Prediction in an Elderly Population Using Machine Learning
Rose, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kws241 · Cited by 193
Dyslipoproteinemia in systemic lupus erythematosus
Ettinger, W. H., Goldberg, A. P., Applebaum-Bowden, D. M., & Hazzard, W. R. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90762-5 · Cited by 191
Coronary risk associated with age and sex of parental heart disease in the Framingham Study
Schildkraut, J. M., Myers, R. H., Cupples, L. A., Kiely, D. K., & Kannel, W. B. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90477-3 · Cited by 187
Self-citationCardiovascular risk factors: when should we treat?
Tonkin, A. M., Lim, S. S., & Schirmer, H. (2003) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05092.x · Cited by 186
The Peripheral Vascular Consequences of Smoking
Krupski, W. C. (1991) · Annals of Vascular Surgery · doi:10.1007/bf02329389 · Cited by 181
Davis, R. A. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00083-9 · Cited by 175
Diet, Exercise and the Metabolic Syndrome
Pitsavos, C. S., Panagiotakos, D. B., Weinem, M., & Stefanadis, C. (2006) · The Review of Diabetic Studies · doi:10.1900/rds.2006.3.118 · Cited by 177
Cardiac risk factors in patients with diabetes mellitus and major depression
Katon, W. J., Lin, E. H. B., Russo, J. E., Korff, M. V., Ciechanowski, P. S., Simon, G., Ludman, E. J., Bush, T. M., & Young, B. A. (2004) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2004.30405.x · Cited by 171
A systematic review of standing and treadmill desks in the workplace
MacEwen, B. T., MacDonald, D. J., & Burr, J. F. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.11.011 · Cited by 166
Development and validation of a brief dementia screening indicator for primary care
Barnes, D. E., Beiser, A., Lee, A., Langa, K. M., Koyama, A. K., Preis, S. R., Neuhaus, J. M., McCammon, R. J., Yaffe, K. S., Seshadri, S. S., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.11.006 · Cited by 168
Cardiac morbidity and mortality related to orthotopic liver transplantation
Therapondos, G., Flapan, A. D., Plevris, J. N., & Hayes, P. C. (2004) · Liver Transplantation · doi:10.1002/lt.20298 · Cited by 165
Liu, L. L., Dzankic, S., & Leung, J. M. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.t01-1-50303.x · Cited by 164
Trastuzumab-related cardiotoxicity in the elderly: a role for cardiovascular risk factors
Serrano, C., Cortés, J., Mattos‐Arruda, L. D., Bellet, M., Gómez, P., Saura, C., Pérez, J., Vidal, M. J., Muñoz‐Couselo, E., Carreras-Soler, M.-J., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr348 · Cited by 161
The Framingham Heart Study's Impact on Global Risk Assessment
Bitton, A., & Gaziano, T. A. (2010) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2010.04.001 · Cited by 164
Felmeden, D. C. (2003) · American Journal of Hypertension · doi:10.1016/s0895-7061(02)03149-7 · Cited by 155
Blood Pressure and Body Mass Index in Long-Term Survivors of Testicular Cancer
Haugnes, H. S., Aass, N., Fosså, S. D., Dahl, O., Klepp, O., Wist, E., Wilsgaard, T., & Bremnes, R. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.882 · Cited by 154
Chapter 5 Biomarkers Related To Aging In Human Populations
Crimmins, E. M., Vasunilashorn, S. M., Kim, J. K., & Alley, D. E. (2008) · Advances in clinical chemistry · doi:10.1016/s0065-2423(08)00405-8 · Cited by 159
Concept and usefulness of cardiovascular risk profiles
Kannel, W. B., D’Agostino, R. B., SULLIVAN, L. M., & Wilson, P. W. F. (2004) · American Heart Journal · doi:10.1016/j.ahj.2003.10.022 · Cited by 151
Self-citationDealing with Missing Predictor Values When Applying Clinical Prediction Models
Janssen, K. J. M., Vergouwe, Y., Donders, A. R. T., Harrell, F. E., Chen, Q., Grobbee, D. E., & Moons, K. G. M. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.115345 · Cited by 152
Contribution of the framingham study to preventive cardiology
Kannel, W. B. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90203-2 · Cited by 149
Self-citationLeaverton, P. E., Sorlie, P. D., Kleinman, J. C., Dannenberg, A. L., Ingster, L. M., Kannel, W. B., & Cornoni‐Huntley, J. C. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90129-9 · Cited by 146
Self-citation
Metadata
- Authors
- Kannel, W. B., McGee, D., & Gordon, T.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Kannel, William B.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1976-07
- Volume
- 38
- Issue
- 1
- Pages
- 46-51
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2031564429
- Cited by
- 1,189
- References
- 3
- Citations by year
- 2026: 18 · 2025: 30 · 2024: 29 · 2023: 37 · 2022: 31 · 2021: 27 · 2020: 37 · 2019: 30 · 2018: 31 · 2017: 42 · 2016: 36 · 2015: 38 · 2014: 52 · 2013: 48 · 2012: 29
- FWCI
- 21.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- cardiovascular risk profile, coronary artery disease, atherothrombotic brain infarction, hypertensive heart disease, intermittent claudication, serum cholesterol, blood pressure, smoking history, electrocardiogram, impaired glucose tolerance, risk function, disease incidence, prophylaxis
- MeSH terms
- Adult, Age Factors, Aged, Cardiovascular Diseases, Female, Cardiomegaly, Humans, Hypercholesterolemia, Hypertension, Life Style, Male, Massachusetts, Middle Aged, Obesity, Probability, Regression Analysis, Risk, Sex Factors, Smoking, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review